title: Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.
abstract: IL-12 is a heterodimeric cytokine that has been shown to enhance natural killer (NK) and cytotoxic T lymphocyte (CTL) responses, and to induce IFN-gamma production in vitro. In this study, we have examined the effects in vivo of administering purified murine rIL-12 to normal mice. Daily injections of rIL-12 i.p. (1 ng to 10 micrograms/day) caused dose-dependent enhancement of NK cell lytic activity in the spleens and livers of treated mice. Histologic examination of the livers of IL-12-treated mice revealed focal mononuclear cell infiltrates, and flow cytometry studies indicated that the livers of IL-12-treated mice contained increased numbers of NK cells, CD8+ T cells, and monocytes. Liver and splenic lymphoid cells from IL-12-treated mice, unlike liver and splenic lymphoid cells from control mice, spontaneously secreted IFN-gamma in vitro, suggesting that they had been induced by IL-12 to produce IFN-gamma in vivo. Consistent with this, IFN-gamma could be detected in the serum of IL-12-treated mice. In mice which had been immunized by footpad injection of allogeneic splenocytes, daily administration of rIL-12 i.p. was shown to enhance the specific CTL response in the draining lymph nodes. Thus, these studies demonstrate that IL-12 can enhance NK and CTL activity and induce IFN-gamma production in vivo, as well as in vitro, and suggest possible mechanisms by which IL-12 may exert therapeutic effects in the treatment of some tumors and infectious diseases.
authors.affiliation: Department of Inflammation/Autoimmune Diseases, Hoffmann-La Roche Inc., Nutley, NJ 07110.
authors.forename: M K
authors.initials: MK
authors.lastname: Gately
authors.forename: R R
authors.initials: RR
authors.lastname: Warrier
authors.forename: S
authors.initials: S
authors.lastname: Honasoge
authors.forename: D M
authors.initials: DM
authors.lastname: Carvajal
authors.forename: D A
authors.initials: DA
authors.lastname: Faherty
authors.forename: S E
authors.initials: SE
authors.lastname: Connaughton
authors.forename: T D
authors.initials: TD
authors.lastname: Anderson
authors.forename: U
authors.initials: U
authors.lastname: Sarmiento
authors.forename: B R
authors.initials: BR
authors.lastname: Hubbard
authors.forename: M
authors.initials: M
authors.lastname: Murphy
mesh_terms: D000818:Animals; D003601:Cytotoxicity Tests, Immunologic; D016130:Immunophenotyping; D007371:Interferon-gamma / Q000096:biosynthesis* / Q000187:drug effects; D018664:Interleukin-12; D007378:Interleukins / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D011994:Recombinant Proteins / Q000494:pharmacology; D013154:Spleen / Q000187:drug effects; D013602:T-Lymphocytes, Cytotoxic / Q000187:drug effects*; D014407:Tumor Cells, Cultured
chemical_list: D007378:Interleukins; D011994:Recombinant Proteins; D018664:Interleukin-12; D007371:Interferon-gamma